Crimean–Congo hemorrhagic fever (CCHF) is a high‑risk viral disease transmitted by ticks and livestock that can cause rapid fever, organ failure and internal bleeding, and it has no approved vaccines or treatments. A new preclinical study in npj Vaccines reports encouraging results for an experimental vaccine tested in mice. The work comes from a team that includes Scott Pegan at the University of California, Riverside and collaborators at several public agencies.
The vaccine platform is a virus-like replicon particle: it enters cells like the real virus but lacks the genetic material needed to replicate, so it cannot cause infection. Unlike most vaccines that target surface proteins, this candidate focuses on internal proteins, particularly the N protein that is normally hidden inside the virus. The authors suggest the N protein focus may underlie the unusually rapid antibody response and the platform's success.
Earlier work showed protection within three days of a single dose. In the new study researchers measured antibodies after one or two doses and found them detectable for up to 18 months in mice, an interval the team says roughly corresponds to several years in humans. Antibody levels in one- and two-dose groups were similar for about nine months, while animals receiving a booster developed stronger, more stable antibodies and showed better, longer-lasting protection.
Next steps include scaling production under Good Manufacturing Practice (GMP) ahead of human clinical trials. Partners at the Centers for Disease Control and Prevention are already exploring the same platform for other pathogens such as Nipah virus. The study lists collaborators at the CDC, the US Department of Agriculture and Auburn University, and notes partial support from the CDC and the National Institute of Allergy and Infectious Diseases of the NIH; the findings do not necessarily represent the official CDC position.
Difficult words
- replicon particle — a noninfectious agent that mimics virus entry into cells
- n protein — an internal viral protein normally hidden inside the virus
- good manufacturing practice (GMP) — rules and processes ensuring safe, quality production
- preclinical — research done before human clinical trials
- booster — an extra vaccine dose to increase immunity
- antibody — a blood protein that fights infectionantibodies
- transmit — to pass a disease from one to anothertransmitted
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What advantages or disadvantages might come from targeting an internal viral protein like the N protein rather than a surface protein?
- The study found similar antibody levels after one and two doses for about nine months. How could this result affect decisions about vaccination schedules?
- Partners are testing this platform for other pathogens. Why might researchers try the same vaccine platform for different viruses, and what factors would influence that decision?
Related articles
AI tool to improve cause-of-death data in low-income countries
Researchers created CODA, an AI tool to give more accurate causes of death in low-income countries where few deaths have documented causes. CODA can work in communities and health facilities and will begin limited trials.
Alzheimer’s tests may show different brain changes in women and men
A Georgia State University study finds common cognitive screens like the MMSE may not detect the same brain changes in women and men. The results suggest sex-aware interpretation of tests and further study of hormones and genetics.
Which childhood food allergies are outgrown?
Many children outgrow milk and egg allergies, while peanut, tree nut, sesame and shellfish allergies often persist. Factors such as IgE levels, allergy severity and genetics affect whether a child becomes tolerant and which treatments help.
Father’s microplastic exposure affects offspring health
A mouse study found that when fathers were exposed to microplastics, their offspring developed metabolic problems. Female offspring showed diabetic signs and researchers linked the effect to changes in sperm small RNAs; the work was published in the Journal of the Endocrine Society.